Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Rogier H. van Doorn"'
Autor:
Yoel Lubell, Nga T. T. Do, Kinh V. Nguyen, Ngan T. D. Ta, Ninh T. H. Tran, Hung M. Than, Long B. Hoang, Poojan Shrestha, Rogier H. van Doorn, Behzad Nadjm, Heiman F. L. Wertheim
Publikováno v:
Antimicrobial Resistance and Infection Control, Vol 7, Iss 1, Pp 1-6 (2018)
Abstract Aim We assess the cost-benefit implications of C-reactive protein (CRP) testing in reducing antibiotic prescription for acute respiratory infection in Viet Nam by comparing the incremental costs of CRP testing with the economic costs of anti
Externí odkaz:
https://doaj.org/article/0555ee3ad4384e29ade93684a81b2d64
Autor:
Paul C, Adamson, Hao Thi Minh, Bui, Thomas, Kesteman, Diep Thi Ngoc, Nguyen, Thuong Thi Hong, Nguyen, Tan, Van Le, Rogier H, van Doorn, Jeffrey D, Klausner, Giang Minh, Le
Publikováno v:
The Lancet Microbe. 4:e201-e202
Autor:
Phuong Thi Lan Nguyen, Hung Thi Mai Tran, Hai Anh Tran, Thai Duy Pham, Tan Minh Luong, Thanh Ha Nguyen, Lien Thi Phuong Nguyen, Tho Thi Thi Nguyen, Ha Thi An Hoang, Chi Nguyen, Duong Nhu Tran, Anh Duc Dang, Masato Suzuki, Thanh Viet Le, Anne-Laure Bañuls, Marc Choisy, Rogier H. Van Doorn, Huy Hoang Tran
Publikováno v:
Am J Trop Med Hyg
Plasmid-Mediated Colistin Resistance 1 (mcr-1) was first reported in 2015 and is a great concern to human health. In this study, we investigated the prevalence of mcr-1 and mcr-1-positive Escherichia coli (MCRPEC) and the association in infection sta
Autor:
Ana Bonell, Lucie Contamin, Pham Quang Thai, Hoang Thi Thanh Thuy, Rogier H van Doorn, Richard White, Behzad Nadjm, Marc Choisy
Background: Tuberculosis (TB) is a major global health burden, with an estimated quarter of the world’s population being infected. The World Health Organization (WHO) launched the “End TB Strategy” in 2014 emphasising knowing the epidemic. WHO
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::22897e7fd5f6b819adb742a181c040b4
https://doi.org/10.21203/rs.2.14415/v1
https://doi.org/10.21203/rs.2.14415/v1
Autor:
Vu P, Thao, Thuy, Le, Estee M, Török, Nguyen T B, Yen, Tran T H, Chau, Suzanne, Jurriaans, H Rogier, van Doorn, Rogier H, van Doorn, Menno D, de Jong, Jeremy J, Farrar, Sarah J, Dunstan
Publikováno v:
Antiviral therapy, 17(5), 905-913. International Medical Press Ltd
Background Access to antiretroviral therapy (ART) for HIV-infected individuals in Vietnam is rapidly expanding, but there are limited data on HIV drug resistance (HIVDR) to guide ART strategies. Methods We retrospectively conducted HIVDR testing in 2